MedPath

Specific immune response in atezolizumab and bevacizumab

Not Applicable
Recruiting
Conditions
Hepatocellular carcinoma
Registration Number
JPRN-UMIN000047777
Lead Sponsor
Kanazawa University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1) patients refusal 2) inadequate patients

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath